Christopher Bradley

Christopher Bradley is a seasoned professional in the biotechnology and healthcare sectors, currently serving as CEO and Co-Founder of Matter Bio since September 2022 and CEO and Founder of Loki Therapeutics since December 2019. With a background in academia as an Adjunct Professor at New York University, Bradley also contributed as a Fellow at the On Deck Longevity Biotech Fellowship from September 2021 to October 2023. Prior experience includes advisory roles at Particle Health, and executive leadership at Comcast, where Bradley worked as Executive Director of Product & Data Management. Bradley co-founded Mana Health, which was acquired by Comcast NBC Universal, and has conducted noteworthy graduate research at Columbia University Irving Medical Center and NYU Tandon School of Engineering, holding a Master’s Degree in Computer Science and a Bachelor’s Degree in Neuroscience & Cell Biology from Rutgers University.